Ventana Medical Systems, Inc., is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide. The company passionately pursues its mission to improve the lives of all patients afflicted with cancer. Ventana Medical Systems discover, develop, and deliver medical diagnostic systems and biopsy based cancer tests that are shaping the future of healthcare. As the leading supplier of cancer diagnostic systems to the pathology market, Ventana manufactures over 220 cancer tests with related instruments right here in southern Arizona for 80 countries, and most importantly, for 4 million people afflicted with cancer yearly around the world. Ventana products provide healthcare professionals with a total solution for all critical steps involved in the analysis of tissue biopsies. This pioneering company also offers premier workflow solutions to improve laboratory efficiency and preserve patient safety. Ventana is committed to accelerating the discovery and development of new cancer tests that allow pathologists to analyze patient samples at the molecular level to help determine the best course of therapy for each individual patient. Ventana enables this with its global leadership as the number one Pharma Industry Partner of Choice in the development and commercialization of companion diagnostics for cancer patients. Ventana Medical Systems is a member of the Roche Group that is drawing on powerful partnerships with world-class scientific institutions.

Paige was founded in 2017 by Thomas Fuchs, Dr.Sc., and colleagues from Memorial Sloan Kettering Cancer Center. The Company builds computational pathology products designed so patients and their care teams can make effective, more informed treatment decisions. With this new class of diagnostic devices positioned to drive the future of pathology, Paige created a platform to deliver this novel technology to pathologists to transform their workflow and increase diagnostic confidence and productivity. Paige’s lightweight platform was purpose-built with pathologists to offer an intuitive user experience, and minimize IT burden and costs while ensuring patient safety and data privacy. Paige’s products deliver insights to pathologists so they can arrive efficiently at more precise diagnoses for patients. Paige is the first company to receive FDA breakthrough designation for computational pathology products.

Corista LLC is an American private company located in Concord, MA, that develops healthcare workflow software. It was founded in 2005 by Richard Y. Wingard and Elizabeth M. Wingard. Elizabeth M. Wingard has been the CEO since the inception date.\nThe company says this about itself: Corista delivers the industry's most extensive array of workflow, analytical and collaborative tools for pathology. Medical centers can seamlessly integrate with LIS/EHRs in a unified digital environment of whole-slide, gross and static pathology images. Physicians have 21st-century tools to collaborate, communicate, teach and report with access to 'best of breed' image analytics. Specialists can receive digital consults from remote physicians and patients from across the globe, and investigator-initiated researchers have a research and development platform to develop and apply their algorithms.

Mikroscan is committed to partnering with the pathology community by providing technology-enabled products and services that increase a pathologist’s reach, remove barriers to workload efficiency, and enable new discoveries. Their solutions are utilized in hospitals, clinics, universities, and research institutions all over the world. From mobile MOHS labs to medical schools, their technology serves a variety of applications in anatomic pathology, veterinary pathology, teaching, and research settings. Deployed on a tablet, laptop, and desktop systems, Mikroscan’s local and cloud-based solutions address some of the most challenging issues associated with pathology today. Mikroscan was founded in 2011 and headquartered in Carlsbad, California.

NantOmics develops cloud-based molecular profiling tools that help guide cancer patients. It is a molecular diagnostics company, develops molecular profiling solutions that identify personalized treatment options for cancer patients and their providers at the point of care. It offers GPS Cancer test that provides a molecular profile of patient’s cancer to inform personalized treatment strategies to oncologists and OncoPlexDx Targeted Proteomic panel that provides quantitative protein biomarker information for multiple clinically relevant proteins yielding insights into the biology driving the growth of the patient’s cancer. Patrick Soon-Shiong founded NantOmics in 2012, with its headquarters in Culver City, California. NantOmics operates as a subsidiary of NantWorks.

Pathware is on a mission to fundamentally improve healthcare by bringing computational microscopy and AI to the Point-of-Care in order to help pathologists and proceduralists accurately diagnose and treat diseases earlier and more precisely, ultimately saving lives globally.

Sectra is a company that creates and sells products in secure communication and medical information technology.

Proscia is a software company that is accelerating pathology’s digital transformation to change the way we understand diseases like cancer. Its Concentriq digital pathology platform and powerful AI applications are advancing the 150-year-old standard of research and diagnosis towards a data-driven discipline, unlocking new insights that accelerate discovery, improve patient outcomes, and fulfill the promise of precision care. Leading diagnostic laboratories and 10 of the top 20 pharmaceutical companies rely on Proscia’s software each day.

SpIntellx has the first-mover advantage in Precision Pathology and Spatially Intelligent Biology by applying truly unbiased spatial analytics software powered by explainable AI to decipher the complex cancer biology. SpIntellx’s software solutions have the potential to unlock a plethora of new applications in medicine and research by answering the fundamental question “Why?”, thus revealing the underlying patient-specific disease network biology, across each stage of the drug development, diagnostics, and treatment pipelines.

The Japanese Cancer Research Foundation supports the establishment of a cancer institute and its affiliated hospital. It has been leading the research and treatment of cancer thru activities integrating basic and clinical research. It shows their accomplishments in cancer research and treatment over a long history. It is one of the the world-s institutes in bioscience. They are making accomplishments in the treatment of cancer its related diseases with efficient medical staff and leading-edge medical equipment.

INFINITT's technological power and service has been recognized by customers all across the world. Since the launch of the INFINITT PACS in 1998, they have developed solutions 100 percent compliant with international standards such as DICOM, HL7, IHE, and HIPAA. Every year they participate in the IHE Connectathon, demonstrating their products' interoperability and compliance with IHE presentation profiles. Their efforts have been well received, both at home and abroad, as demonstrated by their technology being selected as one of the top ten innovative technologies in Korea and #1 ranking in Best in KLAS Awards: Software and Services for four consecutive years, from 2009 to 2012. INFINITT PACS, INFINITT's flagship product, is the dominant player in the Korean PACS Market, representing about 70 percent of the market share. To maintain their current standing domestically and grow further in the global market, they will keep striving with all their efforts.

London Health Sciences Centre Research, Inc. (doing business as Lowson Health Research Institute) is a private company headquartered in Canada. The firm operates as a hospital.

Hong Kong Applied Science and Technology Research Institute (ASTRI) was founded by the Government of the Hong Kong Special Administrative Region in 2000 with the mission of enhancing Hong Kong’s competitiveness in technology-based industries through applied research. ASTRI’s core R&D competences in various areas are organized under seven Technology Divisions, namely Communications Technologies, Electronics Components, IC Design (Analog), IC Design (Digital), Opto-electronics, Security and Data Sciences, and Software and Systems. Four areas of applications including financial technologies, intelligent manufacturing, next generation networks, and medical and health are identified for major pursuit.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

aetherAI is dedicated to developing web-based digital pathology workflow system and AI-powered diagnostic support. Its mission to use state-of-the-art information technology to improve the quality of healthcare.

Konica Minolta Inc. is an Innovative Company and continues to create inspiring products and services in the field of imaging. An innovative corporation that continues to create inspiring products and services in the field of imaging. A global corporation that leads the market by advanced technologies and reliability. The Konica Minolta brand shows intellectual creativity with its challenging, reliable, friendly personality. Four unique characteristics help realize the ideal value of the brand: broad technical expertise covering the entire imaging field; a culture relentlessly committed to creating great products and services; unique product groups developed from integrated technologies; a marketing service network that swiftly copes with customers’ needs. The essence of their brand is Konica Minolta’s comprehensive technological expertise that yields highly original innovations, which are a constant source of surprise to customers. The logo is a representation of their brand value and company name and expresses what Konica Minolta offers to customers. The Konica Minolta Group owns a wide array of specialized technologies and technologies that support the competitiveness and attractiveness of their products. These technologies are defined as our core technologies, totaling twelve – four in materials, two in optics, two in nano-fabrication and four in imaging fields. Throughout their history, they have expanded and advanced these technologies, integrating them at whole new levels so that they are the driving force of our production activities. They continuously strive to integrate these technologies into innovative products with new functions and added value that contribute to the daily lives of people at home and at work. Naturally, this also includes our range of Business Solution products.

Shenzhen Keya Medical Technology Co. Ltd. is a Chinese company. The firm develops AI based medical device which helps to analyze physiological functional assessment of the coronary arteries.